Alantolactone inhibits cervical cancer progression by downregulating BMI1

Cervical cancer is the second most common cancer in women. Despite advances in cervical cancer therapy, tumor recurrence and metastasis remain the leading causes of mortality. High expression of BMI1 is significantly associated with poor tumor differentiation, high clinical grade, and poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaodong, Xu, Hongxia, Dai, Tianyu, Xie, Lixia, Zhao, Qiang, Hao, Xincai, Sun, Yan, Wang, Xuanbin, Jiang, Nan, Sang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085045/
https://www.ncbi.nlm.nih.gov/pubmed/33927214
http://dx.doi.org/10.1038/s41598-021-87781-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085045/
https://www.ncbi.nlm.nih.gov/pubmed/33927214
http://dx.doi.org/10.1038/s41598-021-87781-z

Ejemplares similares